AR115758A1 - Composición que comprende la cepa de lactobacillus plantarum cjlp475 y la cepa de lactobacillus plantarum cjlp243 y uso de la misma - Google Patents
Composición que comprende la cepa de lactobacillus plantarum cjlp475 y la cepa de lactobacillus plantarum cjlp243 y uso de la mismaInfo
- Publication number
- AR115758A1 AR115758A1 ARP190101959A ARP190101959A AR115758A1 AR 115758 A1 AR115758 A1 AR 115758A1 AR P190101959 A ARP190101959 A AR P190101959A AR P190101959 A ARP190101959 A AR P190101959A AR 115758 A1 AR115758 A1 AR 115758A1
- Authority
- AR
- Argentina
- Prior art keywords
- composition
- lactobacillus plantarum
- composition according
- plantarum strain
- group
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 11
- 240000006024 Lactobacillus plantarum Species 0.000 title abstract 4
- 235000013965 Lactobacillus plantarum Nutrition 0.000 title abstract 4
- 229940072205 lactobacillus plantarum Drugs 0.000 title abstract 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 230000036039 immunity Effects 0.000 abstract 3
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 235000020183 skimmed milk Nutrition 0.000 abstract 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 abstract 1
- 102000004127 Cytokines Human genes 0.000 abstract 1
- 108090000695 Cytokines Proteins 0.000 abstract 1
- 229920001353 Dextrin Polymers 0.000 abstract 1
- 239000004375 Dextrin Substances 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 229920002774 Maltodextrin Polymers 0.000 abstract 1
- 239000005913 Maltodextrin Substances 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 abstract 1
- 210000000941 bile Anatomy 0.000 abstract 1
- 239000012141 concentrate Substances 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000002577 cryoprotective agent Substances 0.000 abstract 1
- 235000019425 dextrin Nutrition 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 235000001727 glucose Nutrition 0.000 abstract 1
- 210000002865 immune cell Anatomy 0.000 abstract 1
- 239000006166 lysate Substances 0.000 abstract 1
- 229940035034 maltodextrin Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Animal Husbandry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Birds (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La presente revelación se refiere a una composición que comprende una cepa de Lactobacillus plantarum CJLP475 depositada con el Núm. de Acceso KCCM12287P; y una cepa de Lactobacillus plantarum CJLP243 depositada con el Núm. de Acceso KCCM11045P, y el uso de las mismas. Reivindicación 2: La composición de acuerdo con la reivindicación 1, en la que la composición tiene una actividad de resistencia a los ácidos, de resistencia a la bilis y de mejora de la inmunidad, e incrementa la secreción de citocinas por medio de la promoción de la activación de las células inmunitarias. Reivindicación 4: La composición de acuerdo con la reivindicación 1, en la que la composición tiene una actividad antiviral contra el virus de la diarrea epidémica porcina (PEDV). Reivindicación 10: La composición de acuerdo con la reivindicación 1, en la que (a) y (b) están en forma de una cepa de sí misma, un lisado de la misma, un cultivo de la misma, un concentrado de la misma o una forma seca de la misma. Reivindicación 12: La composición de acuerdo con la reivindicación 11, en el que el crioprotector es por lo menos uno seleccionado del grupo que consiste en glicerol, trehalosa, maltodextrina, leche descremada en polvo y almidón, y el excipiente es por lo menos uno seleccionado del grupo que consiste en glucosa, dextrina y leche descremada. Reivindicación 13: La composición de acuerdo con la reivindicación 10, en el que el uso de la composición se selecciona entre el grupo que consiste en: el uso para el incremento de la inmunidad y el suministro de una actividad antiviral, el uso en productos farmacéuticos, piensos o aditivos para piensos, alimentos y cosméticos. Reivindicación 14: Un método para el incremento de la inmunidad de un sujeto, que comprende: la administración de la composición de una cualquiera de las reivindicaciones 1 a 13 a un sujeto.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20180081910 | 2018-07-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR115758A1 true AR115758A1 (es) | 2021-02-24 |
Family
ID=69143036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190101959A AR115758A1 (es) | 2018-07-13 | 2019-07-11 | Composición que comprende la cepa de lactobacillus plantarum cjlp475 y la cepa de lactobacillus plantarum cjlp243 y uso de la misma |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11458175B2 (es) |
| EP (1) | EP3620513A4 (es) |
| JP (1) | JP6918144B2 (es) |
| KR (1) | KR102175115B1 (es) |
| CN (1) | CN111032857B (es) |
| AR (1) | AR115758A1 (es) |
| BR (1) | BR112019026602A2 (es) |
| PH (1) | PH12019502698A1 (es) |
| SG (1) | SG11202000113QA (es) |
| WO (1) | WO2020013672A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102550271B1 (ko) * | 2020-09-07 | 2023-07-03 | 주식회사 휴먼바이오 | 참외를 포함하는 반려동물용 간식 조성물 및 이의 제조방법 |
| CN116042420A (zh) * | 2022-10-27 | 2023-05-02 | 江苏农林职业技术学院 | 一株巴氏毕赤酵母y2及其益生菌制剂和应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100585391B1 (ko) * | 2002-01-24 | 2006-06-01 | 주식회사 프로바이오닉 | 돼지 전염성위장염 (TGE) 코로나바이러스 및 유해 미생물 억제 활성을 갖는 신규 락토바실러스 프란타럼 Probio-38 및 이를 함유하는 생균활성제 |
| WO2005007834A1 (en) * | 2003-07-23 | 2005-01-27 | Probionic Corp. | Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus |
| DE602004030922D1 (de) * | 2003-08-21 | 2011-02-17 | Otsuka Pharma Co Ltd | Milchsäurebakterien mit mucosa-immunpotenzierungseffekt |
| CN102014673B (zh) | 2008-03-28 | 2014-07-30 | 雀巢产品技术援助有限公司 | 用于怀孕的雌性哺乳动物的以增强她们的后代的免疫性的益生菌剂 |
| KR101075558B1 (ko) | 2008-12-03 | 2011-10-20 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
| KR101075557B1 (ko) | 2008-12-03 | 2011-10-20 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
| KR101046001B1 (ko) | 2009-06-29 | 2011-07-01 | (주)애드바이오텍 | 돼지유행성 설사 또는 돼지전염성 위장염에 대한 항체를 지닌 난황을 함유하는 자돈 사료용 첨가물 조성물 |
| KR101255050B1 (ko) | 2009-07-14 | 2013-04-16 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
| KR101486999B1 (ko) * | 2009-07-22 | 2015-01-28 | 씨제이제일제당 주식회사 | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
| KR101178217B1 (ko) * | 2009-10-28 | 2012-09-07 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
| KR101235561B1 (ko) | 2010-12-09 | 2013-03-21 | 주식회사 제일바이오 | 항바이러스 및 항균 활성을 갖는 락토바실러스 플란타룸 ｃｌｐ-1 균주 및 이를 포함하는 생균제 |
| KR101239806B1 (ko) | 2011-04-01 | 2013-03-06 | 주식회사한국야쿠르트 | 면역증강 활성을 가지는 신규한 락토바실러스 플란타룸 에이취와이 7712 |
| CN102690771B (zh) * | 2012-06-12 | 2014-01-01 | 大连吉翔农业科技有限公司 | 一株功能植物乳杆菌及其应用 |
| FR2997960B1 (fr) * | 2012-11-09 | 2016-08-05 | Inst Nat De La Rech Agronomique (Inra) | Nouvelle souche bacterienne de lactobacillus plantarum et utilisation de cette souche |
| KR101406168B1 (ko) | 2013-05-03 | 2014-06-13 | 씨제이제일제당 (주) | 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물 |
| WO2015021530A1 (en) * | 2013-08-12 | 2015-02-19 | Mansel Griffiths | Antiviral methods and compositions comprising probiotic bacterial molecules |
| KR20150044764A (ko) | 2013-10-17 | 2015-04-27 | 주식회사 토비코 | 신규한 락토바실러스 플란타럼 및 그 용도 |
| WO2016022028A1 (en) * | 2014-08-08 | 2016-02-11 | Universiteit Utrecht Holding B.V. | Mutant porcine epizootic diarrhea virus for use in a vaccine |
| CN104480032B (zh) * | 2014-10-22 | 2021-07-09 | 海泰合加(天津)信息科技有限公司 | 一株具有增强免疫活性的植物乳杆菌 |
| KR101778575B1 (ko) | 2015-07-17 | 2017-09-14 | 주식회사 빙그레 | 락토바실러스 속 균주를 포함하는 생균제 조성물, 동물사료용 첨가제 및 동물사료 조성물 |
| WO2017105140A1 (ko) | 2015-12-17 | 2017-06-22 | 씨제이제일제당(주) | 장내 생존율이 증대된 유산균의 코팅 방법 |
| CN106434411B (zh) * | 2016-06-16 | 2019-11-08 | 四川农业大学 | 一种大熊猫源植物乳酸杆菌及应用 |
| KR102032703B1 (ko) | 2017-11-30 | 2019-11-08 | 재단법인 순창군건강장수연구소 | 락토바실러스 플란타룸 mifi-sy3 균주를 이용한 아로니아 발효액의 제조방법 |
| CN108102959B (zh) | 2017-12-23 | 2020-06-02 | 浙江大学 | 人源性降胆固醇植物乳杆菌zy08及其应用 |
-
2019
- 2019-07-11 AR ARP190101959A patent/AR115758A1/es unknown
- 2019-07-12 KR KR1020190084718A patent/KR102175115B1/ko active IP Right Grant
- 2019-07-12 SG SG11202000113QA patent/SG11202000113QA/en unknown
- 2019-07-12 JP JP2019563242A patent/JP6918144B2/ja active Active
- 2019-07-12 US US16/619,804 patent/US11458175B2/en active Active
- 2019-07-12 EP EP19805879.4A patent/EP3620513A4/en active Pending
- 2019-07-12 CN CN201980003708.3A patent/CN111032857B/zh active Active
- 2019-07-12 BR BR112019026602-0A patent/BR112019026602A2/pt unknown
- 2019-07-12 WO PCT/KR2019/008683 patent/WO2020013672A1/ko unknown
- 2019-11-28 PH PH12019502698A patent/PH12019502698A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP6918144B2 (ja) | 2021-08-11 |
| US11458175B2 (en) | 2022-10-04 |
| US20210361724A1 (en) | 2021-11-25 |
| EP3620513A4 (en) | 2021-04-21 |
| CN111032857A (zh) | 2020-04-17 |
| EP3620513A1 (en) | 2020-03-11 |
| SG11202000113QA (en) | 2020-02-27 |
| JP2020529827A (ja) | 2020-10-15 |
| KR20200007744A (ko) | 2020-01-22 |
| PH12019502698A1 (en) | 2020-06-08 |
| WO2020013672A1 (ko) | 2020-01-16 |
| KR102175115B1 (ko) | 2020-11-09 |
| BR112019026602A2 (pt) | 2020-06-30 |
| CN111032857B (zh) | 2023-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR115757A1 (es) | Composición que comprende la cepa cjlp475 de lactobacillus plantarum y la cepa cjlp17 de lactobacillus plantarum y el uso de la misma | |
| WO2016044605A8 (en) | Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy | |
| CO2017002166A2 (es) | Proteínas de fusión de interleucina 2 / receptor de interleucina-2 alfa | |
| MX2017014787A (es) | Poblaciones bacterianas para promover la salud. | |
| AR115758A1 (es) | Composición que comprende la cepa de lactobacillus plantarum cjlp475 y la cepa de lactobacillus plantarum cjlp243 y uso de la misma | |
| BR112018075032A2 (pt) | proteínas de hemaglutinina do vírus influenza e seus uso | |
| PE20170908A1 (es) | VARIANTES DE INTERFERON a2b | |
| AR078601A1 (es) | Composiciones inmunogenicas de antigenos de staphylococcus aureus | |
| MY160610A (en) | Multipurpose gel for vaginal dryness with direct and delayed effect | |
| MX342716B (es) | Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza. | |
| EA201892735A1 (ru) | Состав вакцины против hiv | |
| MX2019006047A (es) | Oligosacaridos para generacion de sabor. | |
| WO2017132332A8 (en) | Chimeric hepatitis d virus antigen and hepatitis b virus pre s1 genes for use alone or in vaccines contaning hepatitis b virus genes | |
| AR089618A1 (es) | Composiciones detergentes | |
| MY189495A (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
| CL2016002442A1 (es) | Rnasa para su uso en el tratamiento o la prevención de infecciones virales. | |
| MX2020005554A (es) | Vacunas y composiciones inmunogenas para zika y metodos para usarlas. | |
| ZA201908610B (en) | Il-15 protein complex pharmaceutical composition and uses thereof | |
| ES2721755T3 (es) | Vacunas contra el virus de la tilapia del lago | |
| AR119653A1 (es) | Cepa cjlp475 de lactobacillus plantarum que tiene efectos antivirales e inmunomoduladores y una composición que comprende la misma | |
| AR101715A1 (es) | Composiciones útiles para diagnosticar infección latente por mycobacterium tuberculosis | |
| MX2016014868A (es) | Metodos para secar por congelacion y rehidratar productos biologicos. | |
| CL2017001706A1 (es) | Empleo de probióticos en el incremento de la fertilidad masculina. | |
| BR112014004261A2 (pt) | diagnósticos de vacina melhorada | |
| BR112018007036A2 (pt) | agentes de fermentação |